Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Checkpoint Therapeutics Inc (CKPT) is now available.
Checkpoint Therapeutics, Inc. has strengthened its corporate governance by appointing Dr. Amit Sharma to its Board of Directors, effectively addressing a previous deficiency with Nasdaq’s independence requirements. Dr. Sharma, with no disclosed conflicts of interest, will serve until the next annual meeting where stockholders will have a chance to elect him. His addition signifies a commitment to independent oversight, a key factor for investor confidence in the integrity of the company’s management.
For detailed information about CKPT stock, go to TipRanks’ Stock Analysis page.